Detalles de la búsqueda
1.
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT.
Eur Heart J Cardiovasc Pharmacother
; 2024 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38678009
2.
C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease.
J Am Coll Cardiol
; 82(5): 414-426, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37495278
3.
C-Reactive Protein and Risk of Cardiovascular Events and Mortality in Patients with Various Cardiovascular Disease Locations.
Am J Cardiol
; 197: 13-23, 2023 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37218417
4.
Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
Int J Cardiol
; 379: 66-75, 2023 05 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36907452
5.
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery disease.
Eur J Prev Cardiol
; 30(18): 1950-1962, 2023 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37409348
6.
Personalized lifetime prediction of survival and treatment benefit in patients with heart failure with reduced ejection fraction: The LIFE-HF model.
Eur J Heart Fail
; 25(11): 1962-1975, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691140
7.
Outcomes of second opinions in general internal medicine.
PLoS One
; 15(7): e0236048, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645107
8.
Standardized reporting of co-morbidity outcome after bariatric surgery: low compliance with the ASMBS outcome reporting standards despite ease of use.
Surg Obes Relat Dis
; 16(11): 1673-1682, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859526
9.
Reply: C-Reactive Protein and Heart Failure in Patients With Established Cardiovascular Disease: Evidence From UK Biobank.
J Am Coll Cardiol
; 82(20): e193, 2023 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37940237
Resultados
1 -
9
de 9
1
Próxima >
>>